CARL L GORDON Transaction History

Date Transaction Value Shares Traded Form
Jan 30 2024
BUY
Open market or private purchase
$7,999,992 $18.0 p/Share
444,444
Jan 30 2024
BUY
Conversion of derivative security
-
2,582,884

Also insider at

TPTX
Turning Point Therapeutics, Inc.
KNTE
Kinnate Biopharma Inc. Healthcare
PRVL
Prevail Therapeutics Inc.
TERN
Terns Pharmaceuticals, Inc. Healthcare
ACET
Adicet Bio, Inc. Healthcare
ORIC
Oric Pharmaceuticals, Inc. Healthcare
KROS
Keros Therapeutics, Inc. Healthcare
GMTX
Gemini Therapeutics, Inc. Healthcare
THRX
Theseus Pharmaceuticals, Inc. Healthcare
CMPX
Compass Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
CLG

Carl L Gordon

Director
San Diego, CA

Track Institutional and Insider Activities on AVBP

Follow ArriVent Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVBP shares.

Notify only if

Insider Trading

Get notified when an Arri Vent Biopharma, Inc. insider buys or sells AVBP shares.

Notify only if

News

Receive news related to ArriVent Biopharma, Inc.

Track Activities on AVBP